Trans-ancestry genome-wide association study identifies novel genetic mechanisms in rheumatoid arthritis
Abstract
Trans-ancestry genetic research promises to improve power to detect genetic signals, fine-mapping resolution, and performances of polygenic risk score (PRS). We here present a large-scale genome-wide association study (GWAS) of rheumatoid arthritis (RA) which includes 276,020 samples of five ancestral groups. We conducted a trans-ancestry meta-analysis and identified 124 loci (P < 5 × 10-8), of which 34 were novel. Candidate genes at the novel loci suggested essential roles of the immune system (e.g., TNIP2 and TNFRSF11A) and joint tissues (e.g., WISP1) in RA etiology. Trans-ancestry fine mapping identified putatively causal variants with biological insights (e.g., LEF1). Moreover, PRS based on trans-ancestry GWAS outperformed PRS based on single-ancestry GWAS and had comparable performance between European and East Asian populations. Our study provides multiple insights into the etiology of RA and improves genetic predictability of RA.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The MyEIRA study was funded by grant from Ministry of Health Malaysia (NMRR-08-820-1975) and the Swedish National Research Council (DNR-348-2009-6468). The GENRA study and the CARDERA genetics cohort genotyping were funded by Versus Arthritis (Grant Reference 19739 to ICS). The Nurses Health Study (NHS cohort) is funded by the NIH (R01 AR049880, UM1 CA186107, R01 CA49449, U01 CA176726, and R01 CA67262). The Swedish EIRA study was supported by the Swedish Research Council (to LK, LP and LA).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All cohorts obtained informed consent from all participants by following the protocols approved by their institutional ethical committees. We have complied with all relevant ethical regulations. IRB of participating institutions (including Brigham And Women's Hospital, Osaka University, and Riken) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The summary statistics and the PRS model with the best performance are publicly available at the following link: https://data.cyverse.org/dav-anon/iplant/home/kazuyoshiishigaki/ra_gwas/ra_gwas-10-28-2021.tar. The codes are available at our website: https://github.com/immunogenomics/RA_GWAS.
https://data.cyverse.org/dav-anon/iplant/home/kazuyoshiishigaki/ra_gwas/ra_gwas-10-28-2021.tar
Subject Area
- Addiction Medicine (400)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2952)
- Dermatology (250)
- Emergency Medicine (442)
- Epidemiology (12759)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4594)
- Geriatric Medicine (420)
- Health Economics (729)
- Health Informatics (2927)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (470)
- Neurology (4367)
- Nursing (237)
- Nutrition (640)
- Oncology (2275)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6954)
- Radiology and Imaging (1531)
- Respiratory Medicine (915)
- Rheumatology (439)
- Sports Medicine (385)
- Surgery (490)
- Toxicology (60)
- Transplantation (212)
- Urology (181)